Literature DB >> 7542917

Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease.

D C Davies1, P McCoubrie, B McDonald, K A Jobst.   

Abstract

AIMS/
BACKGROUND: Visual symptoms are a common but not invariable feature of Alzheimer's disease (AD) and such symptoms appear to become more pronounced as the severity of the dementia increases. Pathology in both the pregeniculate and cortical parts of the visual system has been suggested to underlie the visual deficits in AD. In order to investigate the former possibility, the effect of AD on the optic nerve was investigated.
METHODS: Intraorbital segments of optic nerve were taken at autopsy from nine patients with AD and seven patients with no history of psychiatric or neurological disease and no abnormal neuropathology. All patients had functional vision before death and appeared free of retinal, optic nerve, or microvascular disease. The optic nerves were processed into resin, semi-thin sections cut perpendicular to the long axis of each optic nerve, and stained with paraphenylenediamine. The sections were then investigated using an image analysis system and standard morphometric techniques.
RESULTS: There was no significant difference in the mean cross sectional neural area of AD compared with control optic nerves. Neither were there any significant differences between myelinated axon surface density, total axon number, or mean cross sectional axon area in AD compared with control optic nerves.
CONCLUSION: These results indicate that optic nerve degeneration is not a feature of AD and suggest that the visual deficits in the disease result from cortical dysfunction. This view is supported by the fact that visuospatial dysfunction appears to be the most common visual problem in AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542917      PMCID: PMC505173          DOI: 10.1136/bjo.79.6.596

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  45 in total

1.  Alzheimer's disease with prominent visual symptoms. Clinical and metabolic evaluation.

Authors:  M Kiyosawa; T M Bosley; J Chawluk; D Jamieson; N J Schatz; P J Savino; R C Sergott; M Reivich; A Alavi
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

2.  Broad-band visual capacities are not selectively impaired in Alzheimer's disease.

Authors:  D D Kurylo; S Corkin; R P Dolan; J F Rizzo; S W Parker; J H Growdon
Journal:  Neurobiol Aging       Date:  1994 May-Jun       Impact factor: 4.673

3.  Drawing disability in patients with senile dementia.

Authors:  V Moore; M A Wyke
Journal:  Psychol Med       Date:  1984-02       Impact factor: 7.723

4.  Aging of the optic nerve.

Authors:  C L Dolman; A Q McCormick; S M Drance
Journal:  Arch Ophthalmol       Date:  1980-11

5.  Eye tracking dysfunction in Alzheimer-type dementia.

Authors:  J T Hutton; J A Nagel; R B Loewenson
Journal:  Neurology       Date:  1984-01       Impact factor: 9.910

6.  Paraphenylenediamine: a new method for tracing human visual pathways.

Authors:  A A Sadun; L E Smith; K R Kenyon
Journal:  J Neuropathol Exp Neurol       Date:  1983-03       Impact factor: 3.685

7.  A histoquantitative study of the striate cortex and lateral geniculate body in normal, blind and demented subjects.

Authors:  C L Scholtz; K Swettenham; A Brown; D M Mann
Journal:  Neuropathol Appl Neurobiol       Date:  1981 Mar-Apr       Impact factor: 8.090

8.  Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease.

Authors:  G Schlotterer; M Moscovitch; D Crapper-McLachlan
Journal:  Brain       Date:  1984-03       Impact factor: 13.501

9.  Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading.

Authors:  A Brun; E Englund
Journal:  Histopathology       Date:  1981-09       Impact factor: 5.087

10.  Oculomotor reaction time in dementia reflects degree of cerebral dysfunction.

Authors:  F J Pirozzolo; E C Hansch
Journal:  Science       Date:  1981-10-16       Impact factor: 47.728

View more
  20 in total

1.  Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

Review 2.  Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases.

Authors:  Delia Cabrera DeBuc; Gabor Mark Somfai; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

Review 3.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

4.  Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography.

Authors:  Fang Ko; Zaynah A Muthy; John Gallacher; Cathie Sudlow; Geraint Rees; Qi Yang; Pearse A Keane; Axel Petzold; Peng T Khaw; Charles Reisman; Nicholas G Strouthidis; Paul J Foster; Praveen J Patel
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

5.  Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease.

Authors:  Denise A Valenti
Journal:  Int J Alzheimers Dis       Date:  2011-01-05

6.  Density and cross-sectional areas of axons in the olfactory tract in control subjects and Alzheimer's disease: an image analysis study.

Authors:  Richard A Armstrong; Anila B Syed; Christopher U M Smith
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307

7.  Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer's disease compared to glaucoma and control.

Authors:  Sevda Aydin Kurna; Gokcen Akar; Ahmet Altun; Yasemin Agirman; Eren Gozke; Tomris Sengor
Journal:  Int Ophthalmol       Date:  2014-10-05       Impact factor: 2.031

8.  Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma.

Authors:  Christine T Fu; David W Sretavan
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

9.  Mesenchymal stem cell-conditioned medium attenuates the retinal pathology in amyloid-β-induced rat model of Alzheimer's disease: Underlying mechanisms.

Authors:  Shu-Chun Kuo; Chung-Ching Chio; Chao-Hung Yeh; Jui-Ti Ma; Wen-Pin Liu; Mao-Tsun Lin; Kao-Chang Lin; Ching-Ping Chang
Journal:  Aging Cell       Date:  2021-03-30       Impact factor: 9.304

Review 10.  How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?

Authors:  E Jones-Odeh; C J Hammond
Journal:  Eye (Lond)       Date:  2015-09-04       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.